Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier — implications for use of glucosamine in inflammatory disorders-Reference-Cited by-同舟云学术

Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier — implications for use of glucosamine in inflammatory disorders

Published:1998-07 Issue:1 Volume:51 Page:11-15
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

McCarty M.F.

Publisher

Elsevier BV

Subject

General Medicine

Reference63 articles.

1. The neglect of glucosamine as a treatment for osteoarthritis — a personal perspective;McCarty;Med Hypotheses,1994

2. Antireactive properties of glucosamine sulfate;Setnikar;Arzneim-Forsch,1991

3. Antiarthritic effects of glucosamine sulfate studied in animal models;Setnikar;Arzneim-Forsch,1991

4. Method and Agent for Treating Inflammatory Disorders of the Gastrointestinal Tract;Prudden,1977

5. Method for Treatment of Lower Gastrointestinal Tract Disorders;Burton,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin modulation of human plasma kallikrein on different substrates and inhibitors;Biological Chemistry;2006-01-01

2. Inhibitory effect of oral glucosamine administration on platelet activation in guinea pigs;Inflammation and Regeneration;2006

3. Inhibitory action of glucosamine on platelet activation in guinea pigs;Inflammation Research;2005-12

4. Key role of mast cells and their major secretory products in inflammatory bowel disease;World Journal of Gastroenterology;2004

5. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes;World Journal of Gastroenterology;2004